Subsequent Events

6 Months Ended

Jun. 30, 2017

Subsequent Events [Abstract]

Subsequent Events

11. Subsequent events

In July 2017, the Board of Directors approved the Portola Pharmaceuticals, Inc. Inducement Plan, including a share reserve of 1.5 million shares of common stock. The Inducement Plan allows for stock options and restricted stock units to be granted to new employees on substantially the same terms for those awards as our 2013 Equity Incentive Plan. The Inducement Plan was principally adopted to accommodate a reserve of additional shares of common stock for issuance to new employees hired to support commercial operations following the FDA’s approval of Bevyxxa.